Schizophrenia is not officially classified as a neurodevelopmental disorder, but a growing body of evidence shows that it has deep neurodevelopmental roots. The DSM-5 places schizophrenia in its own category, “Schizophrenia Spectrum and Other Psychotic Disorders,” separate from the neurodevelopmental disorders chapter that includes autism and ADHD. Yet the science increasingly tells a more complicated story: the brain changes behind schizophrenia begin long before a person ever experiences psychosis, often traceable to fetal development and early childhood.
What the Neurodevelopmental Hypothesis Says
The neurodevelopmental hypothesis of schizophrenia proposes that disruptions to normal brain development, beginning in the womb or early life, set the stage for psychosis that emerges years or even decades later. The core evidence comes from several directions. Brain imaging consistently shows enlargement of the fluid-filled spaces (ventricles) inside the brain, changes in both gray and white matter, and abnormal layering of neurons in the cortex. These structural differences are often present at the first episode of psychosis, before any medication has been taken, suggesting they were there all along rather than caused by the illness itself. Ventricles in people with schizophrenia are roughly 130% the size of those in unaffected individuals.
Genetic studies point to disruptions in the proteins that guide early brain wiring: neuron migration, the growth of connections between brain cells, and the formation of synapses. Children who later develop schizophrenia also show subtle neurological signs years before any psychiatric symptoms appear, including minor coordination problems and delays in motor development. These “soft signs” are consistent with a brain that developed differently from the start.
Prenatal Risks That Raise the Odds
Some of the strongest evidence for a neurodevelopmental origin comes from what happens before birth. Specific maternal infections during pregnancy are linked to significantly higher rates of schizophrenia in offspring. Prenatal rubella exposure increases the risk 10 to 20 times. Influenza during the first trimester is associated with a 7-fold increase. The parasite that causes toxoplasmosis raises risk about 2.5 times when antibodies are elevated in the mother’s blood.
The common thread appears to be the mother’s immune response rather than the infection itself. Pregnant women whose offspring later developed schizophrenia had nearly double the levels of a specific immune signaling molecule (interleukin-8) during the second trimester compared to controls. Another inflammatory marker, TNF-alpha, has also been linked to psychotic disorders in offspring. This suggests that widespread maternal inflammation, regardless of its trigger, can alter fetal brain development in ways that increase vulnerability to schizophrenia.
Obstetric complications more broadly, including oxygen deprivation during delivery and low birth weight, appear in the histories of people with schizophrenia at higher rates than in the general population.
Early Warning Signs in Childhood
Schizophrenia is typically diagnosed in the late teens to early 30s, with men tending to show symptoms in their late teens to early 20s and women in their late 20s to early 30s. But the trail of subtle differences starts much earlier. Children who go on to develop schizophrenia are more likely to have language disorders, learning difficulties, and problems with attention and working memory years before psychosis appears.
Studies of childhood-onset schizophrenia (a rare and more severe form) illustrate this pattern clearly. Average IQ scores in these children dropped from about 90 before illness onset to 80 afterward, with particularly sharp declines in verbal comprehension. Children with early-onset schizophrenia were nearly three times as likely to have a history of learning disorders compared to those diagnosed as adults (25% vs. 9%). Many also showed impairments in expressive and receptive language, and those with premorbid speech problems tended to have stronger family histories of schizophrenia-spectrum conditions and more obstetric complications at birth.
Why Symptoms Appear in Adolescence
If schizophrenia’s roots are in early brain development, a natural question is why symptoms don’t show up until adolescence or early adulthood. The answer likely involves a normal brain process called synaptic pruning. During adolescence, the brain eliminates a large number of connections between neurons, particularly in the cortex, as part of healthy maturation. This is the brain streamlining itself, removing weak or redundant connections to become more efficient.
Research from Harvard Medical School and the Broad Institute identified a gene called complement component 4 (C4), already known for its role in the immune system, as a key player in this pruning process. C4 tags synapses for removal by triggering another protein to deposit onto them as a “prune me” signal. People who carry genetic variants that produce more C4 activity appear to lose more synapses during this critical developmental window. The result is a brain with fewer connections than normal, which aligns with a long-standing observation: the brains of people with schizophrenia consistently show reduced neural connectivity.
This mechanism elegantly connects two puzzles. It explains why schizophrenia onset coincides with the period of most active synaptic pruning, and it explains how a genetic vulnerability present from birth can remain silent until the teenage years.
Genetic Overlap With Other Neurodevelopmental Conditions
Schizophrenia shares significant genetic territory with autism spectrum disorder, a condition firmly classified as neurodevelopmental. A large genome-wide analysis found a positive genetic correlation between the two conditions, with 11 specific genomic regions influencing both. Interestingly, the relationship may involve opposing mechanisms: autism is associated with an overabundance of synapses and connections, while schizophrenia involves excessive pruning and fewer connections. Some researchers have proposed that the two conditions sit at opposite ends of a neurodevelopmental spectrum.
Shared genes between the two disorders are particularly active during early to mid-fetal brain development, reinforcing the idea that both conditions have roots in how the brain is built before birth. Specific chromosomal regions linked to schizophrenia, including deletions at 22q11.2, 15q11.2, and 1q21.1, cause syndromes that also feature developmental delays, cognitive deficits, and psychosis. The 22q11.2 deletion syndrome alone involves roughly 90 genes and produces deficits in cognitive skills like emotion recognition, visual learning, and executive function alongside elevated psychosis risk.
Neurotransmitter Systems That Mature Late
The two brain chemical systems most implicated in schizophrenia, dopamine and glutamate, both undergo significant changes during adolescent brain maturation. Animal studies show that artificially boosting dopamine production in the brain’s reward and movement pathways during early adolescence produces behavior that resembles schizophrenia. When researchers disrupt hippocampal development in rats during the prenatal period (mimicking a neurodevelopmental insult), the dopamine-producing neurons fire at abnormally high rates.
Studies using neurons derived from people with schizophrenia reveal immature dopamine-producing cells and glutamate-releasing cells that are slower to mature and form fewer synaptic contacts than expected. This delayed maturation of both chemical systems suggests that the brain’s signaling infrastructure never fully develops in people who go on to have schizophrenia, leaving it vulnerable when the demands of adolescent brain reorganization hit.
Why the Classification Still Matters
Despite all this evidence, the DSM-5 maintains schizophrenia in a separate diagnostic category from neurodevelopmental disorders like autism and intellectual disability. This isn’t because the science is wrong. It reflects how psychiatric classification works: the DSM organizes conditions largely by their presenting symptoms and the age at which they’re diagnosed, not by their underlying biology. Schizophrenia’s hallmark symptoms (hallucinations, delusions, disorganized thinking) look different from the developmental delays and behavioral patterns that define the neurodevelopmental category.
The practical reality is that schizophrenia sits in a gray zone. It behaves like a neurodevelopmental disorder in its origins: prenatal insults, genetic disruptions to brain wiring, childhood cognitive differences, and a final trigger during adolescent brain remodeling. But it presents like a psychiatric disorder in its symptoms, which emerge relatively late and center on psychosis rather than developmental milestones. Most researchers now view it as a disorder with a neurodevelopmental foundation that unfolds across a person’s lifespan, with psychosis as the late, visible stage of a process that began decades earlier.